Search Results 1651-1660 of 26081 for stem cell
CAR-T Cell Therapy Program ... Sherman, M.D.. Orthopedic Surgeon. Jacksonville, FL. Areas of focus: Knee replacement, Hip replacement, Hemipelvectomy, Stem cell ...
Hogan, M.B., B.Ch. Internist; Oncologist; Hematologist. Rochester, MN. Areas of focus: Bone marrow transplant, Allogeneic stem cell transplant, Autologous stem ...
Mesenchymal stem cell (MSC) carriers. The team is working to enhance the potency of oncolytic virotherapy by using tumor-homing MSCs as carriers for ...
Study documents safety, improvements from stem cell therapy after spinal cord injury. ROCHESTER, Minn. — A Mayo Clinic study shows stem cells derived from ...
Glioblastoma Stem Cells at the Nexus of Tumor Heterogeneity, Immune Evasion, and Therapeutic Resistance. Cells. 2025 Apr 9; 14 (8) Epub 2025 Apr 09. View ...
... cell (CART- TnMUC1 cells). Participation eligibility. Participant eligibility ... Prior allogeneic stem cell transplant. 7. Active and untreated central ...
Trimethoprim-sulfamethoxazole Graded Administration in Oncology, Hematopoietic Stem Cell Transplant, and Solid Organ Transplant Patients with a History of ...
... stem cell transplant (ASCT) ≥ 100 days prior to registration. Patients must not have received any supplements which have been known to have some anti ...
(Video animation shows blood stem cells dividing and multiplying. Getty Images). Deep inside the body, a slow-growing cluster of mutated blood cells can form.
... stem cell transplant. A Study to Evaluate the Safety and Effectiveness of Idecabtagene Vicleucel to Treat Multiple Myeloma. Jacksonville, Fla., Rochester ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.